End-of-day quote
Other stock markets
|
||
- USD | - |
06-03 | Transcript : CV Sciences, Inc. - Shareholder/Analyst Call | |
05-14 | CV Sciences Seeks M&A Opportunities | CI |
Sales 2022 | 16.2M 22.18M | Sales 2023 | 16M 21.91M | Capitalization | 5.47M 7.48M |
---|---|---|---|---|---|
Net income 2022 | -9M -12.32M | Net income 2023 | 3M 4.11M | EV / Sales 2022 | 0.36 x |
Net Debt 2022 | 917K 1.26M | Net cash position 2023 | 875K 1.2M | EV / Sales 2023 | 0.29 x |
P/E ratio 2022 |
-0.44
x | P/E ratio 2023 |
1.77
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.98% |
Latest transcript on CannaVEST Corp
Managers | Title | Age | Since |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 14-06-15 |
Joerg Grasser
DFI | Director of Finance/CFO | 49 | 18-12-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 14-06-15 |
Jamie Corroon
BRD | Director/Board Member | 54 | 22-07-20 |
William McCorkle
BRD | Director/Board Member | 56 | 22-10-20 |
1st Jan change | Capi. | |
---|---|---|
+43.62% | 749B | |
+39.42% | 605B | |
-6.35% | 351B | |
+19.84% | 328B | |
+8.18% | 292B | |
+11.92% | 216B | |
-2.62% | 214B | |
+1.84% | 167B | |
+7.24% | 165B |